Recent Finacing
Recent Raise
Clinical Genomics develops and commercializes colorectal cancer diagnostics, including Colvera, a two-gene (BCAT1/IKZF1) methylated DNA liquid‑biopsy for recurrence monitoring, and InSure FIT fecal tests offered via CLIA/CAP labs.